Post-stroke seizures in malignant middle cerebral artery infarction treated with decompressive hemicraniectomy: A meta-analysis of predictive factors and clinical outcomes
Kaike Lobo , Felipe Moraes Costa , Rafael Reis de Oliveira , Ruan Pablo da Silva Gomes , Giovana Pereira Lobato Brito , Enzo Gabriel Lacerda Rodrigues , Janilzo de Jesus Mendes Costa Júnior , Ana Luíza Mendonça de Almeida , Yurie Lima Yamada , Yasmin Lamas Medeiros , M Ali Aziz-Sultan
{"title":"Post-stroke seizures in malignant middle cerebral artery infarction treated with decompressive hemicraniectomy: A meta-analysis of predictive factors and clinical outcomes","authors":"Kaike Lobo , Felipe Moraes Costa , Rafael Reis de Oliveira , Ruan Pablo da Silva Gomes , Giovana Pereira Lobato Brito , Enzo Gabriel Lacerda Rodrigues , Janilzo de Jesus Mendes Costa Júnior , Ana Luíza Mendonça de Almeida , Yurie Lima Yamada , Yasmin Lamas Medeiros , M Ali Aziz-Sultan","doi":"10.1016/j.jocn.2025.111835","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Decompressive hemicraniectomy (DHC) is a life-saving intervention for malignant middle cerebral artery (MCA) infarction. However, the additional factors which further increase seizure risk within this high-risk population remain unclear. This <em>meta</em>-analysis aimed to evaluate incremental risk factors for seizure development after DHC in malignant MCA infarction and to assess the association between seizures and clinical outcomes.</div></div><div><h3>Methods</h3><div>We systematically searched PubMed, Embase, and Cochrane Library for studies evaluating risk factors for seizure development after DHC for malignant MCA infarction. Odds ratios (ORs) and mean differences were computed for dichotomous and continuous outcomes, respectively, using 95% confidence intervals (CIs) under a random-effects model. Heterogeneity was assessed with I<sup>2</sup> statistics.</div></div><div><h3>Results</h3><div>Five retrospective cohort studies were included, comprising a total of 456 patients, of whom 195 (42.76 %) developed seizures, and 261 (57.24 %) did not. No significant differences between groups were observed for age, female gender, hypertension, diabetes, dyslipidemia, alcohol consumption, history of previous ischemic event, stroke etiology, hemispheric laterality, presence of reperfusion therapy, stroke limited to MCA territory, hemorrhagic transformation, NIH Stroke Scale scores on admission, and time to craniectomy. However, there was a significantly higher proportion of modified Rankin Scale scores ≤ 3 and a lower mortality rate in patients with seizures when compared with those without.</div></div><div><h3>Conclusion</h3><div>In conclusion, none of the variables analyzed were identified as independent risk factors for seizure development, although there was an increased rate of good functional outcome and lower mortality in patients with seizures, possibly reflecting a time-dependent factor of seizure detection.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"145 ","pages":"Article 111835"},"PeriodicalIF":1.9000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586825008082","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Decompressive hemicraniectomy (DHC) is a life-saving intervention for malignant middle cerebral artery (MCA) infarction. However, the additional factors which further increase seizure risk within this high-risk population remain unclear. This meta-analysis aimed to evaluate incremental risk factors for seizure development after DHC in malignant MCA infarction and to assess the association between seizures and clinical outcomes.
Methods
We systematically searched PubMed, Embase, and Cochrane Library for studies evaluating risk factors for seizure development after DHC for malignant MCA infarction. Odds ratios (ORs) and mean differences were computed for dichotomous and continuous outcomes, respectively, using 95% confidence intervals (CIs) under a random-effects model. Heterogeneity was assessed with I2 statistics.
Results
Five retrospective cohort studies were included, comprising a total of 456 patients, of whom 195 (42.76 %) developed seizures, and 261 (57.24 %) did not. No significant differences between groups were observed for age, female gender, hypertension, diabetes, dyslipidemia, alcohol consumption, history of previous ischemic event, stroke etiology, hemispheric laterality, presence of reperfusion therapy, stroke limited to MCA territory, hemorrhagic transformation, NIH Stroke Scale scores on admission, and time to craniectomy. However, there was a significantly higher proportion of modified Rankin Scale scores ≤ 3 and a lower mortality rate in patients with seizures when compared with those without.
Conclusion
In conclusion, none of the variables analyzed were identified as independent risk factors for seizure development, although there was an increased rate of good functional outcome and lower mortality in patients with seizures, possibly reflecting a time-dependent factor of seizure detection.
期刊介绍:
This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology.
The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.